BioPharma Credit PLC
BPCP.L · LSE
6/30/2025 | 12/31/2024 | 6/30/2024 | 12/31/2023 | |
|---|---|---|---|---|
| Revenue | £56 | £45 | £79 | £57 |
| % Growth | 24% | -42.7% | 38.3% | – |
| Cost of Goods Sold | £7 | £0 | £0 | £0 |
| Gross Profit | £84 | £45 | £79 | £57 |
| % Margin | 149.1% | 100% | 100% | 100% |
| R&D Expenses | £0 | £0 | £0 | £0 |
| G&A Expenses | £11 | -£5 | £7 | £20 |
| SG&A Expenses | £11 | -£5 | £7 | £20 |
| Sales & Mktg Exp. | £0 | £0 | £0 | £0 |
| Other Operating Expenses | £0 | £0 | £0 | £0 |
| Operating Expenses | £11 | -£5 | £7 | £20 |
| Operating Income | £73 | £50 | £72 | £38 |
| % Margin | 129.2% | 110.9% | 90.9% | 65.6% |
| Other Income/Exp. Net | £0 | £0 | -£0 | -£0 |
| Pre-Tax Income | £73 | £50 | £72 | £38 |
| Tax Expense | £0 | £0 | £0 | -£0 |
| Net Income | £53 | £50 | £72 | £38 |
| % Margin | 94.3% | 111.1% | 90.8% | 65.6% |
| EPS | 0.046 | 0.042 | 0.058 | 0.029 |
| % Growth | 9.8% | -27.2% | 100.3% | – |
| EPS Diluted | 0.046 | 0.042 | 0.058 | 0.029 |
| Weighted Avg Shares Out | 1,150 | 1,222 | 1,246 | 1,303 |
| Weighted Avg Shares Out Dil | 1,150 | 1,222 | 1,246 | 1,303 |
| Supplemental Information | – | – | – | – |
| Interest Income | £0 | £1 | £0 | £0 |
| Interest Expense | £0 | £0 | £0 | £0 |
| Depreciation & Amortization | -£73 | £72 | -£72 | -£38 |
| EBITDA | £53 | £0 | £0 | -£0 |
| % Margin | 94.3% | 0% | 0% | -0% |